GSK keeps top spot in 2012 sales

Published: 2013-04-12 07:00:00

Updated: 2013-04-12 07:00:00

GSK kept its number 1 ranking in terms of revenue last year from the leader board of multinational drug makers, but struggles this year against Novartis Korea which continued to overtake the top position, according to Yakup.com, a pharmaceutical information provider.

According to the data reco...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK